Immorta Bio (2021) by Immorta Bio

Record 031 · Therapeutics · 2021

50%21.31.X

Immorta Bio

Immorta Bio

“Personalized regenerative immunotherapies against aging and cancer.”

Immorta Bio works on patient-derived regenerative and immune approaches. Small, ambitious, filed as a therapeutics line not a clinic.

Therapeutics at the immune-aging seam.

Pre-seed & seed. Filed from the Top Tier Impact landscape.

Official site
  • Personalized immune
  • Aging + oncology

Immune, then regenerate.